COVID-19 Meltdown and Pharma’s Big Money Win
Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]
Former CDC Director’s Net Worth Estimated at $13.5 Million
Julie Gerberding, MD, who served as director of the U.S. Centers for Disease Control and Prevention (CDC) from 2002 to 2009,1 2 and joined Merck & Co. as president of Merck Vaccines division in January 2010,3 4 recently sold 102,073 shares of her Merck stock for approximately $$9.119 million. This represented just under half of […]
Chinese Pharmaceutical Industry Competes for Vaccine Market Share
China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to start selling their own version of drugs previously available only through global pharmaceutical giants Pfizer, Merck and GlaxoSmithKline.1 Cecolin, developed by Innovax, will compete in the Human Papilloma Virus (HPV) arena against Merck’s Gardasil and […]
Is a Bill Requiring Your Children to Get Every CDC Recommended Vaccination Coming to Your State?
As vaccine-related bills are being introduced into state legislatures this month, a bill (HB1090) has been proposed in the Virginia legislature to require school children to receive every dose of all current and future vaccines added to the recommended childhood vaccine schedule by the Advisory Committee on Immunization Practices (ACIP) appointed by the U.S. Centers […]
Vaccine Market Valued at $93 Billion by 2026
A recent report by Fortune Business Insights projects the value of the world market for vaccines to reach $93.08 billion by 2026, with a Compound Annual Growth Rate (CAGR) of 10.7 percent during the forecast period.1 One of the main drivers of the vaccine market is the need for greater supplies of vaccines, given stricter government […]
GlaxoSmithKline Partners with Viome to Develop New Vaccines
Vaccine manufacturer GlaxoSmithKline (GSK) of the United Kingdom has partnered with Viome, a gut microbiome test company in Seattle, Washington to better understand bacteria that live in the digestive tract and the role they play in the body’s immune system response.1 According to Emmanuel Hanon, senior vice president for research and development at GSK Vaccines, […]